$241 Million is the total value of Tavio Capital LLC's 15 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -24,671 | -100.0% | -0.37% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -79,856 | -100.0% | -4.33% | – |
HUM | Exit | HUMANA INC | $0 | – | -34,062 | -100.0% | -4.50% | – |
CELG | Exit | CELGENE CORP | $0 | – | -182,027 | -100.0% | -6.35% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -152,840 | -100.0% | -8.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
ANTHEM INC | 10 | Q2 2019 | 22.5% |
BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
RETROPHIN INC | 9 | Q1 2019 | 3.4% |
ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
HUMANA INC | 8 | Q4 2019 | 37.8% |
UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-10-01 |
13F-HR | 2020-08-13 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-13 |
13F-HR | 2019-11-13 |
13F-HR | 2019-08-13 |
13F-HR | 2019-05-14 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-13 |
13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.